About Hedia
Hedia is a company based in Copenhagen (Denmark) founded in 2015 by Lars Christian Lund Suhr, Christina Kildentoft, and Peter Lucas. Hedia has raised $19 million across 8 funding rounds from investors including European Union and EIC Fund. Hedia offers products and services including Hedia Diabetes Assistant and Hedia Education. Hedia operates in a competitive market with competitors including Ryse Health, Chunying Medical Technology and Ellerca Health, among others.
- Headquarter Copenhagen, Denmark
- Founders Lars Christian Lund Suhr, Christina Kildentoft, Peter Lucas
- Stage Minicorn
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Hedia Aps
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$19 M (USD)
in 8 rounds
-
Latest Funding Round
$1.91 M (USD), Seed
Nov 28, 2024
-
Investors
European Union
& 1 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Hedia
Hedia offers a comprehensive portfolio of products and services, including Hedia Diabetes Assistant and Hedia Education.
App that calculates insulin doses and tracks glucose for diabetes management.
Resources for diabetes self-management and healthcare professional training.
Funding Insights of Hedia
Hedia has successfully raised a total of $19M across 8 strategic funding rounds. The most recent funding activity was a Seed round of $1.91 million completed in November 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Hedia
Hedia has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include European Union and EIC Fund.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Government agency and accelerator focusing on innovative startups and SMEs
|
Locked | Locked | Locked | |
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Locked | Locked | Locked |
Investor details for Hedia
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Hedia
Investment portfolio details for Hedia
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Hedia
Detailed financials for Hedia
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Hedia Comparisons
Peer comparison for Hedia
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Hedia
Hedia operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Ryse Health, Chunying Medical Technology and Ellerca Health, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Comprehensive diabetes management services are delivered via technology.
|
|
| Locked | Locked | Locked |
An AI virtual assistant is developed for diabetes patient support.
|
|
| Locked | Locked | Locked |
Personalized AI-driven solutions for chronic conditions are developed.
|
Detailed competitors of Hedia
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Hedia
Complete news archive for Hedia
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Hedia
Hedia was founded in 2015 and raised its 1st funding round 3 years after it was founded.
Hedia is headquartered in Copenhagen, Denmark.
Lars Christian Lund Suhr is the current CEO of Hedia. They have also founded this company.
Hedia is a funded company, having raised a total of $19M across 8 funding rounds to date.
Hedia was founded in 2015 in Copenhagen, Denmark, as a provider in the health technology sector. A mobile application known as Diabetes Assistant, classified as a class IIb medical device, is offered to support the management of insulin-dependent diabetes. Operations focus on tools that assist in achieving stable blood glucose levels and related health outcomes. Services are delivered digitally to users in Europe.
Hedia's top competitors include Ryse Health, Ellerca Health and Chunying Medical Technology.
Hedia offers Hedia Diabetes Assistant and Hedia Education.
Hedia has 2 investors. Key investors include European Union, and EIC Fund.
The valuation of Hedia is $15.92M as of Feb 2024.